Status:
UNKNOWN
Clinical Proteomic Research for the Brain
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Ischemic Brain Injury
Stroke
Eligibility:
All Genders
Brief Summary
The study of plasma and urine proteomic profiles in patients with ischemic brain injury is important to better understanding of the mechanisms by which thrombolytic agents or other therapy affects cli...
Eligibility Criteria
Inclusion
- Case Inclusion and
Exclusion
- Inclusion Criteria:
- Ischemic brain injury within 12 hours of symptom onset;
- Including primary ischemic brain injury from embolism or arterial occlusion or secondary due to increased ICP after trauma, subarachnoid hemorrhage.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00983723
Start Date
July 1 2005
End Date
July 1 2016
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Proteomics Research Center, Massachusetts General Hospital
Boston, Massachusetts, United States, 02114